News & Events

What’s happening at InnoCore?

Discover what InnoCore has been doing with its world-class technology, SynBiosys®.

Groningen, The Netherlands — 02 February 2026

InnoCore Appoints Hans de Backer as New CEO to Accelerate Global Expansion in Long Acting Injectable Drug Development

We are proud to announce the appointment of Hans de Backer as Chief Executive Officer. Hans joins the company with a proven track record as a strategy‑driven business leader, recognized for delivering sustainable growth, shepherding complex organizations, and building energized, high‑performance teams.
Read the full story
Stockholm - NLS
Stockholm, 8 & 9 September
Nordic Life Science Days – Stockholm
Discover how our long‑acting injectable platforms and controlled‑release expertise can power your next collaboration in one of Europe’s most innovative life‑science ecosystems.
Read the full story
San Diego - Bio International
San Diego, 22 - 25 June 2026
Bio International Convention – San Diego
Discover how our advanced long‑acting injectable technologies deliver better outcomes for patients worldwide.
Read the full story
DDF - Berlin
Berlin, 18 - 20 May 2026
Global Drug Delivery & Formulation Summit (DDF Summit) – Berlin
Join us at the DDF Summit and discover how our advanced long‑acting injectable technologies enable LAI biologics and small molecules.
Read the full story
Basel - 4 & 5 May 2026
Swiss Biotech Day – Basel
Experience the energy of Swiss Biotech Day 2026, and join us as we connect, inspire, and shape the future of biotech in Basel this May.
Read the full story
Bio Europe Spring - Lisbon
Lisbon, 23 - 25 March 2026
Bio-Europe Spring – Lisbon
Meet us at the Bio-Europe Spring in Lisbon from 23rd - 25th of March! Let’s build the future of Biologics and Peptides together.
Read the full story
Galgewater - Leiden
17 November 2025 | Events
Dutch Life Science Conference – Leiden
Join Rob Steendam during his presentation or meet Vincent de Boer and Martin Bakker to discuss our proprietary SynBiosys platform for sustained release of peptides and biologics
Read the full story
10 November 2025 | Innovation & Research
InnoCore receives EU grant for the development of Sustained Release microspheres
We’re thrilled to announce that InnoCore has been awarded a Just Transition Fund (JTF) to develop a peptide microsphere long-acting injectable. This milestone underscores the innovation and impact of our sustained-release platform in metabolic health. Stay tuned as we accelerate toward transformative solutions in peptide delivery.
Read the full story
06 November 2025 | Latest News
InnoCore Strengthens Commitment to Small Molecule Partnerships While Accelerating Growth in Biologics & Peptide Dosage Forms
InnoCore Pharmaceuticals today initiated a new formulation development program focused on a specific small molecule drug substance, reinforcing its long-standing commitment to supporting its customers across a range of molecules.
Read the full story
28 October 2025 | Latest News
InnoCore Pharmaceuticals Presents at PODD Conference 2025
InnoCore attended and presented at the PODD: Partnership Opportunities in Drug Delivery Conference, taking place between 27–28 October 2025 in Boston, MA.
Read the full story

To hear the latest news from InnoCore Pharmaceuticals, you can subscribe at any time.

Sign-up here